Group 1 - The core viewpoint of the report is that Minsheng Securities has given a "recommend" rating to Yirui Technology (688301.SH) based on several positive factors [1] - The net profit margin is expected to significantly improve by Q3 2025, benefiting from cost dilution and optimization of the business structure [1] - The recovery of medical bidding is driving demand for high-end medical imaging equipment, with significant expansion in procurement needs from leading clients in the new energy sector [1] - The growth potential for CT tubes/industrial ray sources and solution services is opening new avenues for growth [1] - The company's equity incentive plan is designed to bind the core team, enhancing alignment with company performance [1]
民生证券给予奕瑞科技“推荐”评级:Q3利润高增,下游回暖,解决方案业务助增长